Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001396677-10-000007
Filing Date
2010-02-05
Accepted
2010-02-05 12:52:04
Documents
1
Period of Report
2010-02-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3412
  Complete submission text file 0001396677-10-000007.txt   5259
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Issuer) CIK: 0001050007 (see all company filings)

EIN.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O NUTRACEUTICAL CORPORATION 1400 KEARNS BOULEVARD, 2ND FLOOR PARK CITY X1 84060
Business Address
Seelos Andrew W (Reporting) CIK: 0001396677 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23731 | Film No.: 10576469